Within the health sector, pharmaceuticals stands out as sub-sector that is particularly prone to corruption. Jillian Kohler is the lead on this research report, which outlines how corruption in the pharmaceutical sector endangers positive health outcomes. Whether it is a pharmaceutical company bribing a doctor for prescribing its medicines irrespective of a health need or a government employee facilitating the infiltration of substandard medicines into the distribution system, public resources can be wasted and patient health put at risk.

Read the report